List of Excipients in Branded Drug EQUATE MUCUS RELIEF

Generic Drugs Containing EQUATE MUCUS RELIEF

Company	Ingredient	NDC	Excipient
Wal-Mart Stores Inc	guaifenesin	49035-284	CARBOMER HOMOPOLYMER TYPE B
Wal-Mart Stores Inc	guaifenesin	49035-284	CELLULOSE, MICROCRYSTALLINE
Wal-Mart Stores Inc	guaifenesin	49035-284	HYPROMELLOSE
Wal-Mart Stores Inc	guaifenesin	49035-284	POVIDONE
WALMART INC	guaifenesin	79903-327	CARBOMER HOMOPOLYMER TYPE B
WALMART INC	guaifenesin	79903-327	CELLULOSE, MICROCRYSTALLINE

What are the Most Frequently-Used Excipients in EQUATE MUCUS RELIEF?

# Of NDCs	Excipient
2	CARBOMER HOMOPOLYMER TYPE B
2	CELLULOSE, MICROCRYSTALLINE
1	COPOVIDONE K25-31
1	FD&C BLUE NO. 1 ALUMINUM LAKE
2	HYPROMELLOSE
1	MAGNESIUM STEARATE

Excipient Strategy and Commercial Opportunities for EQUATE MUCUS RELIEF

Last updated: February 27, 2026

What is the Role of Excipient Strategy in EQUATE MUCUS RELIEF?

Excipient components influence the drug's stability, absorption, taste, and manufacturing process. For EQUATE MUCUS RELIEF—a formulation targeting mucus thinning and expectoration—selecting optimal excipients is essential to ensure efficacy, stability, and regulatory compliance.

Which Excipient Types are Used in EQUATE MUCUS RELIEF?

1. Binder and Disintegrant Agents

• Microcrystalline cellulose (MCC): Offers compressibility and disintegration control.
• Crospovidone: Enhances tablet disintegration, critical for fast onset.

2. Flavoring Agents and Sweeteners

• Artificial sweeteners such as aspartame: Improve palatability.
• Menthol or eucalyptus oil: Provide gustatory and sensory benefits, possibly aiding sensation of relief.

3. Fillers and Bulking Agents

• Lactose monohydrate or sucrose: Increase tablet volume and aid processing.

4. Stabilizers and Preservatives

• Sodium benzoate: Prevent microbial growth.
• Antioxidants like ascorbic acid: Maintain formulation stability within shelf life.

5. Solubilizers and Humectants

• Polyethylene glycol (PEG): Improve solubility or sustain moisture.
• Glycerin: Used in liquid formulations for viscosity and mouthfeel.

How does Excipient Strategy Impact Commercial Success?

Manufacturing Efficiency
Choosing excipients like MCC and crospovidone facilitates high-speed, consistent tablet production. Simplifies scale-up and reduces costs.

Patient Acceptance
Flavoring agents and sweeteners improve compliance, especially critical for pediatric or sensitive populations.

Stability and Shelf Life
Proper stabilizers preserve API integrity. Longer shelf life reduces logistical and storage costs, expanding market reach.

Regulatory and Patent Considerations
Novel excipient combinations or formulations can provide patent opportunities. Regulatory pathways are streamlined with excipients recognized by agencies like the FDA or EMA.

What are the Key Market Opportunities for EQUATE MUCUS RELIEF?

1. Over-the-Counter (OTC) Market Expansion

OTC formulations cater to self-medication, demanding stable, palatable, and convenient products.

2. Pediatric and Geriatric Segments

Palatability and ease of swallowing expand market access. Excipient choice is critical to minimize allergic reactions or gastrointestinal irritation.

3. Alternative Delivery Forms

Liquids, lozenges, or sachets open additional channels, requiring different excipient systems tailored for each form.

4. Geographic Market Penetration

Emerging markets with limited healthcare access prefer OTC products. Regulatory hurdles are lower for formulations with well-known excipients.

5. Patent Expiry & Formulation Innovation

Developing novel excipient or delivery systems can extend patent life or create barriers to generic competition.

How to Optimize Excipient Strategy for Future Growth?

• Prioritize excipients with established regulatory acceptance to accelerate approval.
• Invest in taste-masking technologies to improve compliance.
• Develop multiparticulate or controlled-release systems for targeted delivery.
• Consider excipients that enable alternative forms, such as melt-in-mouth or effervescent tablets.

Key Takeaways

• Excipient selection influences manufacturing, stability, patient adherence, and regulatory approval.
• Formulation components like MCC, crospovidone, sweeteners, and stabilizers play vital roles.
• Market opportunities include OTC expansion, pediatric and geriatric segments, and novel delivery systems.
• Innovation in excipient use can support patent strategies and extend product lifecycle.

FAQs

1. What are the primary excipients used in mucus relief formulations?
Microcrystalline cellulose (MCC), crospovidone, sweeteners like aspartame, flavoring agents, stabilizers such as sodium benzoate, and humectants like glycerin are common.

2. How does excipient choice affect product stability?
Excipients like antioxidants and preservatives prevent degradation and microbial growth, extending shelf life.

3. Are there regulatory barriers to specific excipients in mucus relief drugs?
Regulatory agencies recognize many commonly used excipients, but novel combinations may require additional safety and compatibility data.

4. How can excipient technology improve patient compliance?
Flavoring agents, sweeteners, and innovative delivery forms like melt-in-mouth tablets improve palatability and ease of use.

5. What are the prospects for new excipient innovations in this market?
Developing controlled-release systems, taste-masking innovations, and alternative delivery formats offer growth potential.

---

References

[1] U.S. Food and Drug Administration. (2021). Inactive Ingredients Database. https://www.fda.gov/drugs/drug-approvals-and-databases/inactive-ingredients-database

[2] European Pharmacopoeia. (2022). Excipient monographs. European Directorate for the Quality of Medicines.

[3] Patel, S., & Patel, M. (2020). Recent advances in taste-masking techniques for oral pharmaceuticals. Journal of Drug Delivery Science and Technology, 56, 101580.